glp-1 female fertility The hidden impact of GLP‐1 receptor agonists on endometrial receptivity and implantation - Sola‐Leyva - 2025 - Acta Obstetricia et Gynecologica Scandinavica 👀 Heads up if you're

FDA-labeled warnings include: Risk of thyroid C-cell tumors (contraindicated in patients with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) Pancreatitis (report severe abdominal pain, with or without vomiting) Gallbladder disease (including gallstones and cholecystitis) Acute kidney injury secondary to dehydration from gastrointestinal symptoms Hypoglycemia when used with insulin or insulin secretagogues (dose adjustments may be needed) Diabetic retinopathy complications in patients with type 2 diabetes and pre-existing retinopathy Suicidal behavior and ideation (monitor for depression or suicidal thoughts) Intestinal obstruction/ileus (particularly with severe constipation) These medications are contraindicated during pregnancy and should be discontinued at least two months before a planned pregnancy

#Podiatry #GLP1 #DiabetesCare #FootHealth #Biomechanics #PatientEducation #HealthcareInnovation

Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells

Data collected in humans using GLP-1 receptor agonists do, however, indicate that females are more sensitive to the blood glucose regulating effects of these treatments, and report higher incidences of symptomatic hypoglycemia than males (66)

Regular monitoring and communication with healthcare providers ensures timely identification of concerning symptoms

Instead, the muscle and fat leave quickly, and the facial skin sags